No Data
On November 21, Gilead Sciences-B (01672.HK) spent 0.128 million Hong Kong dollars to repurchase 0.076 million shares.
Gelonghui, November 21丨Eagle Pharma-B (01672.HK) announced that on November 21, 2024, it spent 0.128 million HKD to repurchase 0.076 million shares, with a repurchase price of 1.67-1.7 HKD per share.
On November 20, Gilead Sciences-B (01672.HK) spent 0.499 million Hong Kong dollars to repurchase 0.3 million shares.
Gelonghui, November 20丨Galactrum Pharmaceuticals-B (01672.HK) announced that on November 20, it spent 0.499 million Hong Kong dollars to repurchase 0.3 million shares.
China Grand Pharmaceutical and Healthcare Holdings Limited (01672.HK) spent 0.5022 million Hong Kong dollars on repurchasing 0.3 million shares on November 19th.
On November 19, Gelonghui reported that Gilead Sciences-B (01672.HK) announced the repurchase of 300,000 shares at a cost of HK$0.5022 million on November 19, 2024, with a repurchase price ranging from HK$1.65 to HK$1.68 per share.
On November 18, Songlei Pharmaceutical-B (01672) spent 0.8311 million HKD to buy back 0.5 million shares.
Cale Pharmaceuticals-B (01672) announced that on November 18, 2024, the company invested 0.8311 million...
Pharmaceutical Company-B (01672.HK) spent 0.477 million Hong Kong dollars to repurchase 0.3 million shares on November 13th.
GLEEN Pharmaceutical-B (01672.HK) announced on November 13th that it spent 0.477 million Hong Kong dollars to repurchase 0.3 million shares.
Express News | Ascletis Pharma Inc - Topline Results Expected in Q2 2025
No Data
No Data
